Inventor · disambiguated record
Jerry L. Nadler
Also filed as: NADLER JERRY · NADLER JERRY L
15 granted patents·11 pending applications·215 citations·filing 1996–2023
92Inventor score
Files withDIAKINE THERAPEUTICS INC6HOPE CITY6EASTERN VIRGINIA MEDICAL SCHOOL3MACDONALD TIMOTHY L2NEW YORK MEDICAL COLLEGE2
Top patents by PatentIndex Score
26 records- 0195US7393827B2Pharmaceutical compositions and methods for restoring β-cell mass and functionDIAKINE THERAPEUTICS INC·Filed 2005·Granted Jul 1, 2008·113 cites·1 claims
- 0285US6316458B1Method of enhancing insulin actionCELL THERAPEUTICS INC·Filed 2000·Granted Nov 13, 2001·31 cites·12 claims
- 0384US10266488B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2014·Granted Apr 23, 2019·3 cites·9 claims
- 0481US11274077B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2020·Granted Mar 15, 2022·1 cites·20 claims
- 0581US6693106B2Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)HOPE CITY·Filed 2002·Granted Feb 17, 2004·15 cites·2 claims
- 0680US6893829B2Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease statesHOPE CITY·Filed 2000·Granted May 17, 2005·10 cites·7 claims
- 0779US6485976B1Use of adeno-associated virus (AAV) to deliver genesHOPE CITY·Filed 2000·Granted Nov 26, 2002·19 cites·18 claims
- 0877US10752581B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2019·Granted Aug 25, 2020·1 cites·13 claims
- 0970US2010331248A1Compositions and methods for treating diabetes using lisofylline and islet neogenesis associated peptideDIAKINE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1070US2011052625A1Compositions and methods for treating diabetes using lisofylline analogs and islet neogenesis associated peptideDIAKINE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1166US2008300189A1Pharmaceutical compositions and methods for restoring beta-cell mass and functionDIAKINE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1263US2023233595A1Use of stat4 inhibitors for prevention and treatment of alzheimer's diseaseNEW YORK MEDICAL COLLEGE·Filed 2023·Application pending·0 cites
- 1359US9278098B2Substituted phthalazines for inducing insulin secretion and protecting beta-cellsUniv Virginia Patent Found·Filed 2014·Granted Mar 8, 2016·0 cites·8 claims
- 1459US6486181B1Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease statesHOPE CITY·Filed 2000·Granted Nov 26, 2002·3 cites·1 claims
- 1559US2022257614A1Use of 12-lipoxygenase inhibitors in the treatment of covid-19NEW YORK MEDICAL COLLEGE·Filed 2022·Application pending·0 cites
- 1659US2013122050A1Compositions and methods for treating diabetes using lisofylline analogs and islet neogenesis associated peptideDIAKINE THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 1756US8987321B2Lisofylline analogs and methods for useUniv Virginia Patent Found·Filed 2013·Granted Mar 24, 2015·0 cites·12 claims
- 1856US8481580B2Lisofylline analogs and methods for useMACDONALD TIMOTHY L·Filed 2008·Granted Jul 9, 2013·0 cites·7 claims
- 1955US2010105690A1Lisofylline analogs and methods for useUNIV VIRGINIA·Filed 2009·Application pending·0 cites
- 2054US8871764B2Lisofylline analogs and methods for useMACDONALD TIMOTHY L·Filed 2012·Granted Oct 28, 2014·0 cites·7 claims
- 2151US2024279190A1Compounds for modulating platelet-type 12-(s)-lipoxygenase and methods of use for sameUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2247US6046224A12 (S)--hete receptor blockersHOPE CITY·Filed 1998·Granted Apr 4, 2000·10 cites·15 claims
- 2346US6191169B1Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease statesHOPE CITY·Filed 1996·Granted Feb 20, 2001·9 cites·15 claims
- 2444US2009269313A1Encapsulation systemDIAKINE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2542US2013131140A1Treatment of diabetes and disorders associated with visceral obesity with inhibitors of human arachidonate 12 lipoxygenase and arachidonate 15-lipoxygenaseNADLER JERRY L·Filed 2011·Application pending·0 cites
- 2635US2013096159A1Inhibitors of human 12-lipoxygenaseMALONEY DAVID J·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerry L. Nadler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →